Japan· JP-2649732S3086
フルルビプロフェン
A flurbiprofen product containing フルルビプロフェン, registered in Japan by 救急薬品工業, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Flurbiprofen is registered in 4 of 19 countries.
Countries holding a registration under ATC M01AE09 (flurbiprofen), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Flurbiprofen · ATC M01AE09
4 / 19 countries
- Belgiumprice
- Canada
- Japan
- Switzerlandprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フルルビプロフェン
- Manufacturer
- 救急薬品工業
- Country
- Japan (JP)
- ATC code
- M01AE09
- ATC class
- Flurbiprofen
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
485 interactions on record for flurbiprofen.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flurbiprofen · interactions on record
485 records
- 69 severe
- 299 moderate
- 8 minor
- 27 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
82 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AE09
Flurbiprofen, as other registers publish it.
- CanadaFLURBIPROFENAA PHARMA INC
- CanadaFLURBIPROFENAA PHARMA INC
- SwitzerlandFroben 100 mg, dragéesVerfora SA
- SwitzerlandFroben 100 mg, dragéesVerfora SA
- SwitzerlandFroben 50 mg, dragéesVerfora SA
- SwitzerlandFroben 50 mg, dragéesVerfora SA
- BelgiumStrepfen Suikervrij 8.75 mgReckitt Benckiser (Healthcare)
- Japanフルルビプロフェントクホン
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce4393f7-fd57-4536-904a-c7967c3061e3 GET /v1/drugs/ce4393f7-fd57-4536-904a-c7967c3061e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "７ｃｍ×１０ｃｍ１枚",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2649732S3086",
"category": "外用薬",
"price_yen": 13.1,
"generic_name": "フルルビプロフェン",
"product_name_jp": null,
"therapeutic_class": "2649",
"transitional_expiry": null
}See everything about flurbiprofen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.